Price regulation and parallel imports of pharmaceuticals

Brekke, 2009, Regulation and pricing of pharmaceuticals: reference pricing or price cap regulation?, Eur. Econ. Rev., 53, 170, 10.1016/j.euroecorev.2008.03.004 Brekke, 2011, Reference pricing, competition, and pharmaceutical expenditures: theory and evidence from a natural experiment, J. Public Econ., 95, 624, 10.1016/j.jpubeco.2010.11.015 Brekke, 2013, Margins and market shares: pharmacy incentives for generic substitution, Eur. Econ. Rev., 61, 116, 10.1016/j.euroecorev.2013.02.005 Carone, 2012, Cost-containment policies in public pharmaceutical spending in the EU Danzon, 2000, Does regulation drive out competition in pharmaceutical markets?, J. Law Econ., 43, 311, 10.1086/467458 Ganslandt, 2004, Parallel imports and the pricing of pharmaceutical products: evidence from the European Union, J. Health Econ., 23, 1035, 10.1016/j.jhealeco.2004.03.005 Giaccotto, 2005, Drug prices and research and development investment behavior in the pharmaceutical industry, J. Law Econ., 48, 195, 10.1086/426882 Golec, 2006, European pharmaceutical price regulation, firm profitability, and R&D spending Granlund, 2011, Parallel imports and mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals? Grossman, 2008, Parallel imports and price controls, RAND J. Econ., 39, 378, 10.1111/j.0741-6261.2008.00019.x Jelovac, 2005, Pricing and welfare implications of parallel imports in the pharmaceutical industry, Int. J. Health Care Finance Econ., 5, 5, 10.1007/s10754-005-6599-x Kanavos, 2005, Pharmaceutical parallel trade in Europe: stakeholder and competition effects, Econ. Policy, 20, 751, 10.1111/j.1468-0327.2005.00150.x Kyle, 2007, Pharmaceutical price controls and entry strategies, Rev. Econ. Stat., 89, 88, 10.1162/rest.89.1.88 Kyle, 2010, Strategic responses to parallel trade B.E., J. Econ. Anal. Policy, 11 Malueg, 1994, Parallel imports, demand dispersion and international price discrimination, J. Int. Econ., 37, 167, 10.1016/0022-1996(94)90044-2 Pecorino, 2002, Should the US allow prescription drug reimports from Canada?, J. Health Econ., 21, 699, 10.1016/S0167-6296(02)00035-8 Roy, 2012, Equilibrium parallel import policies and international market structure, J. Int. Econ., 87, 262, 10.1016/j.jinteco.2012.01.007 Valletti, 2006, Parallel trade, international exhaustion and intellectual property rights: a welfare analysis, J. Ind. Econ., 54, 499, 10.1111/j.1467-6451.2006.00298.x Vernon, 2005, Examining the link between price regulation and pharmaceutical R&D investment, Health Econ., 14, 1, 10.1002/hec.897 Vernon, 2008